JP2016529484A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016529484A5 JP2016529484A5 JP2016521841A JP2016521841A JP2016529484A5 JP 2016529484 A5 JP2016529484 A5 JP 2016529484A5 JP 2016521841 A JP2016521841 A JP 2016521841A JP 2016521841 A JP2016521841 A JP 2016521841A JP 2016529484 A5 JP2016529484 A5 JP 2016529484A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- fra
- therapeutic agent
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361837543P | 2013-06-20 | 2013-06-20 | |
| US61/837,543 | 2013-06-20 | ||
| PCT/US2014/043402 WO2014205342A2 (en) | 2013-06-20 | 2014-06-20 | Methods for treatment of ovarian cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016529484A JP2016529484A (ja) | 2016-09-23 |
| JP2016529484A5 true JP2016529484A5 (https=) | 2017-08-03 |
| JP6383787B2 JP6383787B2 (ja) | 2018-08-29 |
Family
ID=52105530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016521841A Expired - Fee Related JP6383787B2 (ja) | 2013-06-20 | 2014-06-20 | 卵巣癌の治療方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20160311921A1 (https=) |
| EP (1) | EP3011013A4 (https=) |
| JP (1) | JP6383787B2 (https=) |
| AU (1) | AU2014284212B2 (https=) |
| BR (1) | BR112015031950A2 (https=) |
| CA (1) | CA2914237A1 (https=) |
| MX (1) | MX2015017950A (https=) |
| WO (1) | WO2014205342A2 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2172487A1 (en) * | 2005-04-22 | 2010-04-07 | Morphotek Inc. | Antibodies with Immune Effector Activity that Internalize in Folate Receptor Alpha-Positive Cells |
| AU2016323968B2 (en) * | 2015-09-17 | 2023-07-06 | Immunogen, Inc. | Therapeutic combinations comprising anti-FOLR1 immunoconjugates |
| WO2019099374A2 (en) * | 2017-11-14 | 2019-05-23 | University Of Virginia Patent Foundation | Compositions and methods for making and using bispecific antibodies |
| CN115925952A (zh) | 2018-03-13 | 2023-04-07 | 东莞凡恩世生物医药有限公司 | 抗叶酸受体1抗体及其用途 |
| US20230074385A1 (en) * | 2019-12-23 | 2023-03-09 | Eisai R&D Management Co., Ltd. | Method for producing eribulin-based antibody-drug conjugate |
| CN117741149A (zh) * | 2024-02-19 | 2024-03-22 | 卡秋(江苏)生物科技有限公司 | 一种用于卵巢癌细胞叶酸受体α的检测试剂盒及其应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4851332A (en) | 1985-04-01 | 1989-07-25 | Sloan-Kettering Institute For Cancer Research | Choriocarcinoma monoclonal antibodies and antibody panels |
| US6351666B1 (en) | 1998-02-27 | 2002-02-26 | Biofield Corp. | Method and apparatus for sensing and processing biopotentials |
| JP3952599B2 (ja) | 1998-07-16 | 2007-08-01 | 松下電器産業株式会社 | 映像表示装置および映像表示方法 |
| WO2000004711A1 (en) | 1998-07-16 | 2000-01-27 | Imageid Ltd. | Image identification and delivery system |
| US6694090B1 (en) | 1998-07-20 | 2004-02-17 | Thomson Licensing S.A. | Method and apparatus for dynamically overriding a ratings limit during playback of a digital program |
| DE69900584T3 (de) | 1998-07-21 | 2009-05-20 | Nxp B.V. | System zur übertragung von daten von einem datenträger nach einer station mittels eines oder zum mindest eines anderen hilfsträgersignals |
| IT1303624B1 (it) | 1998-07-22 | 2000-11-15 | Techint Spa | Dispositivo per elettrodeposizione a cella circonferenziale a flussidifferenziati. |
| DE19833226C1 (de) | 1998-07-23 | 2000-04-20 | Steuler Industriewerke Gmbh | Niederschlagsrohrbündel für Naßelektrofilter |
| DE19833340A1 (de) | 1998-07-24 | 2000-02-10 | Karlsruhe Forschzent | Wurmförmiger Arbeitsmechanismus |
| AU5311599A (en) | 1998-07-24 | 2000-02-14 | Ce Resources Pte Ltd | Array electrophoretic apparatus |
| CN1106227C (zh) | 1998-07-24 | 2003-04-23 | 宝洁公司 | 具有带有改进的汲取管的抽吸分取器的内置袋型包装物 |
| US6386399B1 (en) | 1998-07-24 | 2002-05-14 | Yoshino Kogyosho Co., Ltd. | Container with manual pump |
| IT1301872B1 (it) | 1998-07-24 | 2000-07-07 | Abb Adda S P A | Dispositivo di comando e controllo di interruttori di alta e mediatensione |
| WO2003094929A2 (en) * | 2002-05-06 | 2003-11-20 | University Of Utah Research Foundation | Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents |
| CA2556027C (en) | 2004-02-12 | 2015-11-24 | Morphotek, Inc. | Monoclonal antibodies that specifically block biological activity of a tumor antigen |
| EP2172487A1 (en) | 2005-04-22 | 2010-04-07 | Morphotek Inc. | Antibodies with Immune Effector Activity that Internalize in Folate Receptor Alpha-Positive Cells |
| WO2007002535A2 (en) * | 2005-06-24 | 2007-01-04 | Ciphergen Biosystems, Inc. | Biomarkers for ovarian cancer |
| US8986650B2 (en) * | 2005-10-07 | 2015-03-24 | Guerbet | Complex folate-NOTA-Ga68 |
| AU2007335744A1 (en) * | 2006-12-20 | 2008-06-26 | Alberto A. Gabizon | Method for administration of pegylated liposomal doxorubicin |
| US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
| AU2011323124C1 (en) * | 2010-11-05 | 2016-09-22 | Eisai Inc. | Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers |
| PL2731972T3 (pl) | 2011-07-15 | 2018-06-29 | Eisai R&D Management Co., Ltd. | Przeciwciała skierowane przeciwko receptorowi folianowemu alfa i ich zastosowania |
| HUE049693T2 (hu) * | 2012-08-31 | 2020-10-28 | Immunogen Inc | Diagnosztikai ASSAY-k és készletek a folát receptor 1 kimutatására |
-
2014
- 2014-06-20 JP JP2016521841A patent/JP6383787B2/ja not_active Expired - Fee Related
- 2014-06-20 BR BR112015031950A patent/BR112015031950A2/pt not_active Application Discontinuation
- 2014-06-20 CA CA2914237A patent/CA2914237A1/en not_active Abandoned
- 2014-06-20 US US14/898,905 patent/US20160311921A1/en not_active Abandoned
- 2014-06-20 MX MX2015017950A patent/MX2015017950A/es unknown
- 2014-06-20 EP EP14813679.9A patent/EP3011013A4/en not_active Withdrawn
- 2014-06-20 WO PCT/US2014/043402 patent/WO2014205342A2/en not_active Ceased
- 2014-06-20 AU AU2014284212A patent/AU2014284212B2/en not_active Ceased
-
2019
- 2019-03-19 US US16/357,577 patent/US20190202930A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2011281700B2 (en) | Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancer | |
| JP2016529484A5 (https=) | ||
| US20130121999A1 (en) | Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer | |
| Spiegelberg et al. | The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells | |
| KR20140094594A (ko) | 유방암 치료를 위한 베바시주맙 병용 치료에 대한 혈장 바이오마커 | |
| Kim et al. | Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review | |
| WO2014205342A4 (en) | Methods for treatment of ovarian cancer | |
| Wu et al. | Midkine as a potential diagnostic marker in epithelial ovarian cancer for cisplatin/paclitaxel combination clinical therapy | |
| Gao et al. | CCR7 high expression leads to cetuximab resistance by cross-talking with EGFR pathway in PI3K/AKT signals in colorectal cancer | |
| RU2017136863A (ru) | Способы лечения рака легкого | |
| JP2018516244A5 (https=) | ||
| Kim et al. | Breast cancer stem cells in HER2-negative breast cancer cells contribute to HER2-mediated radioresistance and molecular subtype conversion: clinical implications for serum HER2 in recurrent HER2-negative breast cancer | |
| Zhou et al. | Nuclear translocation of fibroblast growth factor receptor 3 and its significance in pancreatic cancer | |
| EP3216460B1 (en) | Antigen polypeptide for detecting plasma immunological marker-vegfr1 autoantibody and use thereof | |
| Wang et al. | Fork head box M1 regulates vascular endothelial growth factor-A expression to promote the angiogenesis and tumor cell growth of gallbladder cancer | |
| Sun et al. | Expression of annexin A5 in serum and tumor tissue of patients with colon cancer and its clinical significance | |
| WO2021229293A2 (en) | Endogenous retroviruses for the detection, diagnosis, and prognosis of cancer | |
| US20230190752A1 (en) | Compositions and methods for predicting therapeutic outcome | |
| CN121175569A (zh) | Pro-c5测定 | |
| RU2014110270A (ru) | Способ прогнозирования риска гипертензии, связанной с антиангиогенной терапией | |
| HK1181459B (en) | Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancer | |
| HK1184854B (en) | Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancer |